Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Clinical Trial

Efficacy and Safety of a Unani Pharmacopeial Powder Formulation and Sharbat banafsha in Women with Uncomplicated Urinary Tract Infection: A Pilot Self-Control Clinical Trial

Author(s): Arshiya Sultana*, Khaleequr Rahman and Khadija Khaleeq

Volume 21, Issue 4, 2025

Published on: 05 November, 2024

Page: [518 - 530] Pages: 13

DOI: 10.2174/0115734013319264241031105823

Price: $65

Abstract

Background: Antimicrobial resistance is a growing global concern, highlighting the urgent need for effective non-antibiotic alternatives to treat urinary tract infections. Effortlessly blending traditional Unani knowledge with modern scientific evaluation, this study highlights the potential of Unani formulations in managing uncomplicated UTIs. This study's findings underscore the importance of exploring and bridging the gap between Unani medicine and evidence- based practices. This study investigates the efficacy and safety of an Unani Pharmacopeial powder formulation and Sharbat Banafsha in treating women with uncomplicated urinary tract infections (UTI).

Materials and Methods: The pre and post-test pilot self-control clinical study involved 13 participants with uUTI who received 3.5 g powder Unani formulation comprising Lagenaria siceraria (Molina) Standl, Malva sylvestris L., Cucumis sativus L. and Cucumis melo L., Portulaca oleracea L., and Adiantum capillus L. with Sharbat Banafsha (syrup of Viola odorata L.) 25 ml twice daily for 8 days. The primary outcomes were assessed using the urinary tract infection symptoms assessment (UTISA) questionnaire, while secondary outcomes included urine culture and sensitivity, as well as health-related quality of life (HRQoL) assessment using the SF-12 health survey. The data was analyzed, and p<0.05 was considered significant.

Results: The UTISA total score from 15.69 ± 2.18 was reduced to 4.00 ± 5.07 on day 9 with a significance difference (p < 0.001). On day 14, 84.61% of the population had negative cultures. The total SF-12, PCS, and MCS scores showed significant differences from Day 0 to 60 (p>0.05). No adverse effects were reported in both groups. HPLC analysis confirmed the presence of the plant metabolite luteolin in both the powder and syrup.

Conclusion: The data explores the effectiveness of Unani formulations for bacterial urinary tract infections (UTI), showing no adverse effects while also improving the HRQoL of women. These herbal products contain luteolin, a bioactive molecule with antimicrobial properties.

Keywords: Female diseases, health-related quality of life, UTISA questionnaire, uncomplicated urinary tract infection (UTI), Unani Medicine, clinical trial.

« Previous
Graphical Abstract
[1]
Anju PC. A study to evaluate the efficacy of cranberry extract supplements in prevention of recurrent urinary tract infections in female patients. Int J Basic Clin Pharmacol 2020; 9: 1854.
[http://dx.doi.org/10.18203/2319-2003.ijbcp20205122]
[2]
Murugesu S, Selamat J, Perumal V. Phytochemistry, pharmacological properties, and recent applications of Ficus benghalensis and Ficus religiosa. Plants 2021; 10(12): 2749.
[http://dx.doi.org/10.3390/plants10122749] [PMID: 34961220]
[3]
Pandey D, Khanam Z. Urinary tract infections in pregnancy. In: Infect Pregnancy. Singapore: Springer 2022; pp. 367-81.
[http://dx.doi.org/10.1007/978-981-16-7865-3_24]
[4]
Gama CRB, Pombo MAG, Nunes CP, et al. Treatment of recurrent urinary tract infection symptoms with urinary antiseptics containing methenamine and methylene blue: Analysis of etiology and treatment outcomes. Res Rep Urol 2020; 12: 639-49.
[http://dx.doi.org/10.2147/RRU.S279060] [PMID: 33365282]
[5]
Gágyor I, Hummers E, Schmiemann G, et al. Herbal treatment with uva ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: A randomized controlled trial. Clin Microbiol Infect 2021; 27(10): 1441-7.
[http://dx.doi.org/10.1016/j.cmi.2021.05.032] [PMID: 34111592]
[6]
Dason S, Dason JT, Kapoor A. Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J 2013; 5(5): 316-22.
[http://dx.doi.org/10.5489/cuaj.687] [PMID: 22031610]
[7]
Rahman SR, Ahmed MF, Begum A. Occurrence of urinary tract infection in adolescent and adult women of shanty town in Dhaka City, Bangladesh. Ethiop J Health Sci 2014; 24(2): 145-52.
[http://dx.doi.org/10.4314/ejhs.v24i2.7] [PMID: 24795516]
[8]
George C, Norman G, Ramana GV, Mukherjee D, Rao T. Treatment of uncomplicated symptomatic urinary tract infections: Resistance patterns and misuse of antibiotics. J Family Med Prim Care 2015; 4(3): 416-21.
[http://dx.doi.org/10.4103/2249-4863.161342] [PMID: 26288784]
[9]
Chang SJ, Lin CD, Hsieh CH, Liu YB, Chiang IN, Yang SSD. Reliability and validity of a chinese version of urinary tract infection symptom assessment questionnaire. Int Braz J Urol 2015; 41(4): 729-38.
[http://dx.doi.org/10.1590/S1677-5538.IBJU.2014.0046] [PMID: 26401866]
[10]
Gágyor I, Rentzsch K, Strube-Plaschke S, Himmel W. Psychometric properties of a self-assessment questionnaire concerning symptoms and impairment in urinary tract infections: The UTI-SIQ-8. BMJ Open 2021; 11(2): e043328.
[http://dx.doi.org/10.1136/bmjopen-2020-043328] [PMID: 33589460]
[11]
Raz R. Urinary tract infection in postmenopausal women. Korean J Urol 2011; 52(12): 801-8.
[http://dx.doi.org/10.4111/kju.2011.52.12.801] [PMID: 22216390]
[12]
Car J. Urinary tract infections in women: Diagnosis and management in primary care. BMJ 2006; 332(7533): 94-7.
[http://dx.doi.org/10.1136/bmj.332.7533.94] [PMID: 16410583]
[13]
Khan AH. Karachi: Madina Publication 1983.
[14]
Khan A. In: Iksir-i-A’zam. New Delhi: Idarae Kitabus Shifa 2011.
[15]
Qamri M. Ghina Muna. In: Markazi Council Bara Tahiqeqate Tib Unani. New Delhi: Nizami Press 2008.
[16]
Flower A, Wang LQ, Lewith G, Liu JP, Li Q. Chinese herbal medicine for treating recurrent urinary tract infections in women. Cochrane Libr 2015; 2017(6): CD010446.
[http://dx.doi.org/10.1002/14651858.CD010446.pub2] [PMID: 26040964]
[17]
Vahlensieck W, Lorenz H, Schumacher-Stimpfl A, Fischer R, Naber K. Effect of a herbal therapy on clinical symptoms of acute lower uncomplicated urinary tract infections in women: Secondary analysis from a randomized controlled trial. Antibiotics 2019; 8(4): 256.
[http://dx.doi.org/10.3390/antibiotics8040256] [PMID: 31817885]
[18]
Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature 2016; 529(7586): 336-43.
[PMID: 26791724]
[19]
Chandra H, Bishnoi P, Yadav A, Patni B, Mishra A, Nautiyal A. Antimicrobial resistance and the alternative resources with special emphasis on plant-based antimicrobials - A review. Plants 2017; 6(2): 16.
[http://dx.doi.org/10.3390/plants6020016] [PMID: 28394295]
[20]
Sachan AK, Das DR, Kumar M. Carum carvi-an important medicinal plant. J Chem Pharm Res 2016; 8: 529-33.
[21]
Anand U, Jacobo-Herrera N, Altemimi A, Lakhssassi N. A comprehensive review on medicinal plants as antimicrobial therapeutics: Potential avenues of biocompatible drug discovery. Metabolites 2019; 9(11): 258.
[http://dx.doi.org/10.3390/metabo9110258] [PMID: 31683833]
[22]
Manandhar S, Luitel S, Dahal RK. In vitro antimicrobial activity of some medicinal plants against human pathogenic bacteria. In: J Trop Med 2019; 2019: 1895340.
[http://dx.doi.org/10.1155/2019/1895340]
[23]
Afzal S, Ahmad HI, Jabbar A, et al. Use of medicinal plants for respiratory diseases in Bahawalpur, Pakistan. BioMed Res Int 2021; 2021(1): 5578914.
[http://dx.doi.org/10.1155/2021/5578914] [PMID: 33884265]
[24]
Sharma A, Chandraker S, Patel VK, Ramteke P. Antibacterial activity of medicinal plants against pathogens causing complicated urinary tract infections. Indian J Pharm Sci 2009; 71(2): 136-9.
[http://dx.doi.org/10.4103/0250-474X.54279] [PMID: 20336211]
[25]
Arzani A. Qarabadeen Qadri. New Delhi: I’jaz Publishing House 2009.
[26]
Ghani N. Khazainul Advia. New Delhi: Idarae Kitabus Shifa 2001.
[27]
Zaatout H, AlShaikh N, Sallam S, Hammoda H. Phytochemical and biological activities of lagenaria siceraria: An overview. Egypt J Chem 2023; 0(0): 0.
[http://dx.doi.org/10.21608/ejchem.2023.182665.7373]
[28]
Habte G, Tamiru S, Eyasu K. In vivo antimalarial activity of the 80% methanolic crude fruit extract of Lagenaria siceraria (Molina) Standl. against Plasmodium berghei infected mice. Heliyon 2023; 9(4): e15453.
[http://dx.doi.org/10.1016/j.heliyon.2023.e15453] [PMID: 37151678]
[29]
Batiha GES, Tene ST, Teibo JO, et al. The phytochemical profiling, pharmacological activities, and safety of malva sylvestris: A review. Naunyn Schmiedebergs Arch Pharmacol 2023; 396(3): 421-40.
[http://dx.doi.org/10.1007/s00210-022-02329-w] [PMID: 36418467]
[30]
Revathi B, Sasidhar B, Babu GR, Divyalatha J, Devadasu C, Dhachinamoorthi D. Evaluation of antibacterial activity of aqueous extract of Cucumis melo. RJPP 2023; 15(1): 1-4.
[http://dx.doi.org/10.52711/0975-4385.2023.00001]
[31]
Ismail AM. Flavonoid contents of adiantum capillus-veneris L. growing in two different districts from iraqi Kurdistan Northern Iraq. Egypt Acad J Biol Sci H Bot 2017; 8(1): 25-31.
[http://dx.doi.org/10.21608/eajbsh.2017.16815]
[32]
Zhou YX, Xin HL, Rahman K, Wang SJ, Peng C, Zhang H. Portulaca oleracea L.: A review of phytochemistry and pharmacological effects. BioMed Res Int 2015; 2015: 1-11.
[http://dx.doi.org/10.1155/2015/925631] [PMID: 25692148]
[33]
Khare CP. Indian medicinal plants: An illustrated dictionary. New Delhi: Springer Berlin Heidelberg 2007.
[http://dx.doi.org/10.1007/978-0-387-70638-2]
[34]
Clayson D, Wild D, Doll H, Keating K, Gondek K. Validation of a patient‐administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): The UTI Symptom Assessment questionnaire. BJU Int 2005; 96(3): 350-9.
[http://dx.doi.org/10.1111/j.1464-410X.2005.05630.x] [PMID: 16042729]
[35]
Soh SE, Morello R, Ayton D, et al. Measurement properties of the 12-item Short Form Health Survey version 2 in Australians with lung cancer: A Rasch analysis. Health Qual Life Outcomes 2021; 19(1): 157.
[http://dx.doi.org/10.1186/s12955-021-01794-w] [PMID: 34059079]
[36]
Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in. BMJ 2001; 322(7302): 1571.
[http://dx.doi.org/10.1136/bmj.322.7302.1571] [PMID: 11431298]
[37]
Wahid M, Saqib F, Akhtar S, Ali A, Tallei TE, Simal-Gandara J. Mechanistic insights of Cucumis melo L. seeds for gastrointestinal muscle spasms through calcium signaling pathway–related gene regulation networks in WGCNA and in vitro, in vivo studies. Comput Biol Med 2023; 155: 106596.
[http://dx.doi.org/10.1016/j.compbiomed.2023.106596] [PMID: 36773554]
[38]
López-Lázaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 2009; 9(1): 31-59.
[http://dx.doi.org/10.2174/138955709787001712] [PMID: 19149659]
[39]
Terninko II, Onishchenko UE, Frolova A. Phenolic compounds Malva sylvestris by high performance liquid chromatography. PHARMA Innov - J Res 2014; 2014(3): 46-50.
[40]
Karioti A, Furlan C, Vincieri FF, Bilia AR. Analysis of the constituents and quality control of Viola odorata aqueous preparations by HPLC-DAD and HPLC-ESI-MS. Anal Bioanal Chem 2011; 399(4): 1715-23.
[http://dx.doi.org/10.1007/s00216-010-4473-2] [PMID: 21153584]
[41]
Arsene MMJ, Viktorovna PI, Davares AKL, Esther N, Nikolaevich SA. Urinary tract infections: Virulence factors, resistance to antibiotics, and management of uropathogenic bacteria with medicinal plants—A review. J Appl Pharm Sci 2021; 11: 1-12.
[http://dx.doi.org/10.7324/JAPS.2021.110701]
[42]
Qian W, Liu M, Fu Y, et al. Antimicrobial mechanism of luteolin against Staphylococcus aureus and Listeria monocytogenes and its antibiofilm properties. Microb Pathog 2020; 142: 104056.
[http://dx.doi.org/10.1016/j.micpath.2020.104056] [PMID: 32058023]
[43]
Insanu M, Rizaldy D, Silviani V, Fidrianny I. Chemical compounds and pharmacological activities of cucumis genus. Biointerface Res Appl Chem 2021; 12(1): 1324-34.
[http://dx.doi.org/10.33263/BRIAC121.13241334]
[44]
Kashari O. Antibacterial activity and phytochemical screening of calabash seed oil on clinical isolates from skin. Int J Adv Acad Res 2018; 4: 2488-9849.
[45]
Tleubayeva MI, Datkhayev UM, Alimzhanova M, et al. Component composition and antimicrobial activity of CO2 extract of Portulaca oleracea, growing in the territory of Kazakhstan. Scientific World J 2021; 2021: 1-10.
[http://dx.doi.org/10.1155/2021/5434525] [PMID: 33551685]
[46]
Lei X, Li J, Liu B, Zhang N, Liu H. Separation and identification of four new compounds with antibacterial activity from portulaca oleracea L. Molecules 2015; 20(9): 16375-87.
[http://dx.doi.org/10.3390/molecules200916375] [PMID: 26378504]
[47]
Sultana A, Rahman K. Portulaca oleracea Linn: A global panacea with ethnomedicinal and pharmacological potential. Int J Pharm Pharm Sci 2013; 5: 33-9.
[48]
Insanu M, Karimah H, Pramastya H, Fidrianny I. Phytochemical compounds and pharmacological activities of vitis vinifera L.: An updated review. Biointerface Res Appl Chem 2021; 11(6): 13829-49.
[http://dx.doi.org/10.33263/BRIAC115.1382913849]
[49]
Al Akeel R, Mateen A, Alharbi KK, Alyousef AA, Al-Mandeel HM, Syed R. Purification and MIC analysis of antimicrobial proteins from Cucumis sativus L. seeds. BMC Complement Altern Med 2018; 18(1): 121.
[http://dx.doi.org/10.1186/s12906-018-2176-y] [PMID: 29615020]
[50]
Yunusa AK, Dandago MA, Ibrahim SM, Abdullahi N, Rilwan A, Barde A. Total phenolic content and antioxidant capacity of different parts of cucumber (Cucumis sativus L.). Acta Univ Cibiniensis Ser E Food Technol 2018; 22(2): 13-20.
[http://dx.doi.org/10.2478/aucft-2018-0008]
[51]
Ishaq MS, Hussain MM, Siddique Afridi M, et al. In vitro phytochemical, antibacterial, and antifungal activities of leaf, stem, and root extracts of Adiantum capillus veneris. ScientificWorldJournal 2014; 2014: 1-7.
[http://dx.doi.org/10.1155/2014/269793] [PMID: 24592156]
[52]
Mahboubi A, Kamalinejad M, Ayatollahi AM, Babaeian M. Total phenolic content and antibacterial activity of five plants of labiatae against four foodborne and some other bacteria. Iran J Pharm Res 2014; 13(2): 559-66.
[PMID: 25237351]
[53]
Gautam SS, Navneet , Kumar S. The antibacterial and phytochemical aspects of Viola odorata Linn. Extracts against respiratory tract pathogens. Proc Natl Acad Sci, India, Sect B Biol Sci 2012; 82(4): 567-72.
[http://dx.doi.org/10.1007/s40011-012-0064-7]
[54]
Ahmed A, Jahan N, Wadud A, Imam H, Hajera S, Bilal A. Physicochemical and biological properties of adiantum capillus- veneris linn: An important drug of unani system of medicine. Int J Pharm Res 2012; 4: 70-5.
[55]
Inanmdar W, Sultana A, Mubeen U, Rahman K. Clinical efficacy of Trigonella foenum graecum (Fenugreek) and dry cupping therapy on intensity of pain in patients with primary dysmenorrhea. Chin J Integr Med 2016; 2016: 1-8.
[http://dx.doi.org/10.1007/s11655-016-2259-x] [PMID: 27225291]
[56]
Visuvanathan T, Than LTL, Stanslas J, Chew SY, Vellasamy S. Revisiting Trigonella foenum-graecum L.: Pharmacology and therapeutic potentialities. Plants 2022; 11(11): 1450.
[http://dx.doi.org/10.3390/plants11111450] [PMID: 35684222]
[57]
Singh A, Dhariwal S, Navneet D. Traditional uses, antimicrobial potential, pharmacological properties and phytochemistry of viola odorata: A mini review. Journal of Phytopharmacology 2018; 7(1): 103-5.
[http://dx.doi.org/10.31254/phyto.2018.7120]
[58]
Katoch M, Singh A, Singh G, Wazir P, Kumar R. Phylogeny, antimicrobial, antioxidant and enzyme-producing potential of fungal endophytes found in Viola odorata. Ann Microbiol 2017; 67(8): 529-40.
[http://dx.doi.org/10.1007/s13213-017-1283-1]
[59]
Payez AP, Deldadeh N, Ghiasvand SG. Evaluation and comparison of antimicrobial and anticancer effects of aqueous and ethanolic extracts of viola odorata. Multidisciplinary Cancer Investigation 2022; 6(3): 1-6.
[http://dx.doi.org/10.30699/mci.6.3.607-1]
[60]
Mulla İ, Roqaiya M, Imran Khan M. Efficacy of Viola odorata flower decoction in chronic rhinosinusitis. Med J Islamic World Acad Sci 2019; 27(3): 77-84.
[http://dx.doi.org/10.5505/ias.2019.08379]
[61]
Saeedi R, Sultana A, Rahman K. Ethnomedicinal uses nad pharmacological activities of different parts of Cucumus sativus linn: An update. Int J Pharm Sci Res 2020; 11(4): 1549-56.
[http://dx.doi.org/10.13040/IJPSR.0975-8232.11(4).1549-56]
[62]
Schmiemann G, Kniehl E, Gebhardt K, Matejczyk MM, Hummers-Pradier E. The diagnosis of urinary tract infection: A systematic review. Dtsch Arztebl Int 2010; 107(21): 361-7.
[http://dx.doi.org/10.3238/arztebl.2010.0361]

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy